期刊文献+

表达Tie2基因的单核细胞研究进展 被引量:2

Research progress of Tie2-expressing monocytes
原文传递
导出
摘要 肿瘤血管的生成和发展在肿瘤的生长和恶化过程中起着关键作用。一类表达Tie2基因的单核细胞(TEM)通过一些生长因子和化学信号被募集到肿瘤组织中,旁分泌细胞因子促进肿瘤血管的生成和发展。TEM在促进肿瘤血管形成中起着重要作用,与血管内皮细胞祖细胞(EPC)不同的是,TEM只是在肿瘤的血管生成中起促进作用,但在肿瘤周围临近的正常组织中没有发现其存在,TEM被认为是一类肿瘤组织特异性的细胞。以TEM为载体细胞,通过TEM表达抗肿瘤药物,靶向递送的抗肿瘤药物能够有效的抑制肿瘤的生长和恶化。 Neovascularization is significant for tumor growth and progression to malignancy. Tie2 expressing monocytes (TEM) are recruited into tumors by several growth factors and chemokines, and promote tumor angiogenesis in a manner of paracrine. Moreover, TEM, while stimulating tumor angiogenesis, do not actively incorporate into blood vessels as endothelial progenitor cells ( EPC ), but are incorporated in all newforming blood vessel. TEM were found only in tumors and were missing in non-neoplastic tissues adjacent to tumors. Novel anticancer therapies that selectively target tumors by these cells have showed significant antitumor responses and near complete abrogation of metastasis.
出处 《国际免疫学杂志》 CAS 北大核心 2010年第1期5-8,共4页 International Journal of Immunology
基金 基金项目:国家自然科学基金资助项目(30860125)
关键词 TIE2 TEM 肿瘤靶向治疗 Tie2, Tie-2-expressing monocytes, Targeted antieancer therapy
  • 相关文献

参考文献18

  • 1Mantovani A,Allavena P,Sica A. Tumour-associated macrophages as a prototypic type Ⅱ polarised phagocyte population: role in tumour progression. Eur J Cancer,2004,40( 11 ) : 1660-1667.
  • 2Venneri MA, De Palma M, Roca C, et al. Identifi cation of proangiogenic TIE2-expressing monocytes (TEM) in human peripheral blood and cancer. Blood,2007,109(12) :5276-5285.
  • 3De Palma M, Venneri MA, Roca C, et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 2003,9(6) :789-795.
  • 4De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell, 2005,8 ( 3 ) :211-226.
  • 5De Palma M, Mazzieri R, Politi LS, et al. Tumor-targeted interferon-α delivery byTie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell, 2008,14 (4) :299-311.
  • 6Fuchs, EJ. , Whartenby, KA. Hematopoietic stem cell transplantas a platform for tumor immunotherapy. Curr Opin Mol Ther, 2004,6 ( 1 ) :48-53.
  • 7Papapetropoulos A, Fulton D, Mahboubi K, et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem ,2000, 275 ( 13 ) :9102-9105.
  • 8Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, duringembryonic angiogenesis. Cell, 1996,87(7) :1171-1180.
  • 9Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 1997,277 (5322) :55-60.
  • 10Vikkula M, Boon LM, Carraway KL, Calvert JT, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell, 1996,87(7) : 1181-1190.

二级参考文献1

共引文献3

同被引文献13

  • 1罗彦,魏于全.促血管生成素及其受体TEK在血管形成中的调节作用[J].中华医学遗传学杂志,2006,23(1):63-66. 被引量:8
  • 2王康,尚卫华,贾蓬勃,李徐奇,魏光兵.血管生成素受体Tie2在直肠癌中的表达及作用[J].西安交通大学学报(医学版),2006,27(6):599-601. 被引量:4
  • 3Maisonpierre PC, Suri C,Jones PF, et al. Angiopoietin-2, a natural antagonist for TIE2 that disrupts in vivo angiogenesis. Science, 1997, 277 (5322) : 55-60.
  • 4Shu W, Lin Y, Hua R, et al. Cutaneomucosal venous malformations are linked to the TIE2 mutation in a large Chinese family. Experime?ntal Dermatology, 2012, 21 (6) : 456-457.
  • 5Suri C,Jones PF, Patan S, et aL Requisite role of angiopoietin-l, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 1996,87 (7) : 1171-1180.
  • 6De Palma M, Venneri MA, Hoea C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med, 2003, 9: 789-795.
  • 7Fadel BM, Boutet SC, Quetermous T. Functional analysis of the endothelial cell-specific TIE2/Tek promoter identifies unique protein-binding elements. BiochemJ, 1998,330: 335-343.
  • 8LeiJ, Vodovotz Y, Billiar TR. Endothelial specificity of ICAM2, Flt-I, and TIE2 promoters in vitro and in vivo. InternationalJournal of Biological and Life Sciences, 2007, 3 (2) : 124-128.
  • 9De Palma M, Venneri MA, Galli R, et aL TIE2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 2005, 8: 211-226.
  • 10Casazza A, Fu X,Johansson I, et al. Systemic and targeted delivery of semaphorin 3a inhibits tumor angiogenesis and progression in mouse tumor models. Arteriosclerosis, Thrombosis, and Vascular Biology, 2011, 31: 741-749.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部